Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine Dosing for Neuromuscular Blockade Reversal
NCT00847938Phase 3Completed
- Sponsor
- CHD Vendée
- Start
- Mar 2009
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of neostigmine in neuromuscular blockade (NMB), sponsored by CHD Vendée. Started Mar 2009; status: completed.
02
Drugs
neostigmine
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT00847938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00847938.